Home Biotech Stocks Page 106

Biotech Stocks

Latest

Insys Therapeutics Presents Study Results Showing Rapid Absorption Of Epinephrine

ME Staff - February 26, 2019

Veritas Pharma Doses First Subject In Clinical Study Of CTL-X

OWC Pharmaceutical Cannabis Ointment Set To Proceed To PII After Positive PI Data

Reliq Health Technologies Expands Leadership Team As Investigations Continue

Zynerba Gives Clinical Update, Lifelong Impact Of ZYN002

Merck & Co., Inc. (NYSE:MRK) Embattled By Over 400 Pay Discrimination...

Andy Parker - July 22, 2016 0

Market Exclusive’s Inside the FDA: This Week Bezlotoxumab from Merck &...

David Rich - July 22, 2016 0

Biotech Movers: Adamas Pharmaceuticals Inc (NASDAQ:ADMS), Relypsa Inc (NASDAQ:RLYP) and Biogen...

Jennifer Aldershot - July 21, 2016 0

AstraZeneca Plc (NYSE:AZN) Gets European Commission Approval For Qtern

Andy Parker - July 21, 2016 0

WHO Backs Pfizer Inc. (NYSE:PFE) Prevnar 13, Prepares For International Distribution

Andy Parker - July 21, 2016 0

Japan is Breathing Life into the Stem Cell Space, Astellas Pharma...

- July 21, 2016 1

Medtronic PLC (NYSE:MDT)’s Robotic Surgery Partner Mazor Releases Studies Advocating The...

- July 20, 2016 0

MilliporeSigmaTo Build A New Life Science Hub Worth $115 Million In...

- July 20, 2016 0

Can Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Hit Three For Three Tomorrow?

- July 20, 2016 0

Cynapsus Therapeutics Inc (NASDAQ:CYNA) Is Closing In On A Parkinson’s NDA

- July 19, 2016 0

1...105106107...146 Page 106 of 146

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

February 16, 2026

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

February 8, 2026

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

January 26, 2026

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Biotech Stocks

Insys Therapeutics Presents Study Results Showing Rapid Absorption Of Epinephrine

Veritas Pharma Doses First Subject In Clinical Study Of CTL-X

OWC Pharmaceutical Cannabis Ointment Set To Proceed To PII After Positive PI Data

Reliq Health Technologies Expands Leadership Team As Investigations Continue

Zynerba Gives Clinical Update, Lifelong Impact Of ZYN002

Merck & Co., Inc. (NYSE:MRK) Embattled By Over 400 Pay Discrimination...

Market Exclusive’s Inside the FDA: This Week Bezlotoxumab from Merck &...

Biotech Movers: Adamas Pharmaceuticals Inc (NASDAQ:ADMS), Relypsa Inc (NASDAQ:RLYP) and Biogen...

AstraZeneca Plc (NYSE:AZN) Gets European Commission Approval For Qtern

WHO Backs Pfizer Inc. (NYSE:PFE) Prevnar 13, Prepares For International Distribution

Japan is Breathing Life into the Stem Cell Space, Astellas Pharma...

Medtronic PLC (NYSE:MDT)’s Robotic Surgery Partner Mazor Releases Studies Advocating The...

MilliporeSigmaTo Build A New Life Science Hub Worth $115 Million In...

Can Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Hit Three For Three Tomorrow?

Cynapsus Therapeutics Inc (NASDAQ:CYNA) Is Closing In On A Parkinson’s NDA

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

POPULAR CATEGORY